1029P Preclinical development of TCR-modified T cell therapies against mutated KRAS von Salter, H., Pase, L., Brass, A., Bashir, Z., Casarrubea, D., Virding Cullerton, S., Dunst, J., Horta, S., Masia-Balague, M., Lange, J., Parrot, T., Totomi, A., Uchtenhagen, H., Wang, S., Hill, R., Jarvis, R.

Volltext